MasTec upgraded at Goldman Sachs, citing significant new pipeline construction opportunities from midstream oil and gas companies, positioning the company for significant growth.

Tom Cruise is finally getting an Oscar - as will Dolly Parton, Debbie Allen and Wynn Thomas This Dividend Knight Has Grown ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Investing.com -- Goldman Sachs has adjusted its ratings for two players in the U.S. energy services sector, upgrading MasTec (NYSE: MTZ) to Buy while downgrading MYR Group (NASDAQ: MYRG) to Neutral.

Joel Snitman, 81, of Thornhill, Ont., has Type 2 diabetes and says he trusted an ad for a blood glucose testing product he saw on Facebook because it had Diabetes Canada's logo. However, Diabetes ...

The Canada wordmark is ubiquitous in Ottawa. For decades, the logo has been emblazoned on federal buildings and signs, making ...

On Friday, Goldman Sachs analysts upgraded MasTec (NYSE: NYSE: MTZ) stock from Neutral to Buy, increasing the price target to $195 from $156.This decision reflects optimism about MasTec’s role ...

Diabetes Canada says it's received a surge in reports from people who've seen ads for or bought products that use the charity's logos without authorization.Since January, Diabetes Canada says it's had ...

Fintel reports that on June 6, 2025, Goldman Sachs upgraded their outlook for MasTec (NYSE:MTZ) from Neutral to Buy. As of June 1, 2025, the average one-year price target for MasTec is $179.38 ...

Investing.com -- Goldman Sachs has adjusted its ratings for two players in the U.S. energy services sector, upgrading MasTec (NYSE:MTZ) to Buy while downgrading MYR Group (NASDAQ:MYRG) to Neutral.

WATCH: Diabetes Canada and Obesity Canada are issuing warnings over scam posts on social media, some of which can pose a risk. Kyle Benning has the details and more in Health Matter for May 30 ...

In other recent news, MasTec’s financial outlook has been the focus of several analyst firms, with a strong emphasis on the company’s earnings and revenue prospects. Jefferies analyst Julian ...